skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Ferromagnetic resonance for the quantification of superparamagnetic iron oxide nanoparticles in biological materials

Original Research

(2568) Views  (842) Full article downloads

Authors: Lionel F Gamarra, Antonio J daCosta-Filho, Javier B Mamani, et al

Published Date March 2010 Volume 2010:5 Pages 203 - 211
DOI: http://dx.doi.org/10.2147/IJN.S5864

Lionel F Gamarra1,2, Antonio J daCosta-Filho3, Javier B Mamani1, Rita de Cassia Ruiz4, Lorena F Pavon1, Tatiana T Sibov1, Ernanni D Vieira3, André C Silva1, Walter M Pontuschka5, Edson Amaro Jr1,2

1Instituto Israelita de Ensino e Pesquisa Albert Einstein, IIEPAE, São Paulo, Brazil; 2Instituto de Radiologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; 3Instituto de Física de São Carlos, Universidade de São Paulo, São Carlos, Brazil; 4Instituto Butantan, São Paulo, Brazil; 5Instituto de Física, Universidade de São Paulo, São Paulo, Brazil

Abstract: The aim of the present work is the presentation of a quantification methodology for the control of the amount of superparamagnetic iron oxide nanoparticles (SPIONs) administered in biological materials by means of the ferromagnetic resonance technique (FMR) applied to studies both in vivo and in vitro. The in vivo study consisted in the analysis of the elimination and biodistribution kinetics of SPIONs after intravenous administration in Wistar rats. The results were corroborated by X-ray fluorescence. For the in vitro study, a quantitative analysis of the concentration of SPIONs bound to the specific AC133 monoclonal antibodies was carried out in order to detect the expression of the antigenic epitopes (CD133) in stem cells from human umbilical cord blood. In both studies FMR has proven to be an efficient technique for the SPIONs quantification per volume unit (in vivo) or per labeled cell (in vitro).

Keywords: quantification, FMR, ferrofluid, biodistribution, nanoparticles






 

Other articles by Dr Lionel Gamarra



Readers of this article also read:

Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Alogliptin: a new addition to the class of DPP-4 inhibitors
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology
Amino acid management of Parkinson’s disease: a case study
Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines
Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects